Genetically engineered poxviruses for recombinant gene expression, vaccination, and safety
- PMID: 8876137
- PMCID: PMC38059
- DOI: 10.1073/pnas.93.21.11341
Genetically engineered poxviruses for recombinant gene expression, vaccination, and safety
Abstract
Vaccinia virus, no longer required for immunization against smallpox, now serves as a unique vector for expressing genes within the cytoplasm of mammalian cells. As a research tool, recombinant vaccinia viruses are used to synthesize and analyze the structure-function relationships of proteins, determine the targets of humoral and cell-mediated immunity, and investigate the types of immune response needed for protection against specific infectious diseases and cancer. The vaccine potential of recombinant vaccinia virus has been realized in the form of an effective oral wild-life rabies vaccine, although no product for humans has been licensed. A genetically altered vaccinia virus that is unable to replicate in mammalian cells and produces diminished cytopathic effects retains the capacity for high-level gene expression and immunogenicity while promising exceptional safety for laboratory workers and potential vaccine recipients.
Similar articles
-
Vaccinia virus: a tool for research and vaccine development.Science. 1991 Jun 21;252(5013):1662-7. doi: 10.1126/science.2047875. Science. 1991. PMID: 2047875 Review.
-
Poxviruses as vaccine vectors.Comp Immunol Microbiol Infect Dis. 2003 Oct;26(5-6):343-55. doi: 10.1016/S0147-9571(03)00019-5. Comp Immunol Microbiol Infect Dis. 2003. PMID: 12818621 Review.
-
Pox viruses as eukaryotic cloning and expression vectors: future medical and veterinary vaccines.Prog Vet Microbiol Immunol. 1988;4:197-217. Prog Vet Microbiol Immunol. 1988. PMID: 3078866 Review.
-
Poxviruses as expression vectors.Curr Opin Biotechnol. 1997 Oct;8(5):573-7. doi: 10.1016/s0958-1669(97)80031-6. Curr Opin Biotechnol. 1997. PMID: 9353230 Review.
-
Highly attenuated poxvirus vectors.AIDS Res Hum Retroviruses. 1992 Aug;8(8):1445-7. doi: 10.1089/aid.1992.8.1445. AIDS Res Hum Retroviruses. 1992. PMID: 1466978 No abstract available.
Cited by
-
Induction of potent humoral and cell-mediated immune responses by attenuated vaccinia virus vectors with deleted serpin genes.J Virol. 2004 Mar;78(6):2770-9. doi: 10.1128/jvi.78.6.2770-2779.2004. J Virol. 2004. PMID: 14990697 Free PMC article.
-
Immunization with modified vaccinia virus Ankara-based recombinant vaccine against severe acute respiratory syndrome is associated with enhanced hepatitis in ferrets.J Virol. 2004 Nov;78(22):12672-6. doi: 10.1128/JVI.78.22.12672-12676.2004. J Virol. 2004. PMID: 15507655 Free PMC article.
-
Protective immunity in macaques vaccinated with a modified vaccinia virus Ankara-based measles virus vaccine in the presence of passively acquired antibodies.J Virol. 2000 May;74(9):4236-43. doi: 10.1128/jvi.74.9.4236-4243.2000. J Virol. 2000. PMID: 10756037 Free PMC article.
-
Immunogenicity of multiple gene and clade human immunodeficiency virus type 1 DNA vaccines.J Virol. 2003 Dec;77(23):12764-72. doi: 10.1128/jvi.77.23.12764-12772.2003. J Virol. 2003. PMID: 14610198 Free PMC article.
-
Poxvirus vectors: orphaned and underappreciated.J Clin Invest. 2000 Apr;105(8):1031-4. doi: 10.1172/JCI9819. J Clin Invest. 2000. PMID: 10772644 Free PMC article. No abstract available.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials